CERo Therapeutics Holdings, Inc. CERO
0.00 USD 0.00 (-11.00%)
Nov 4, 2026, 3:05 PM EST
0.0041 Day range 0.0046
0.003 52-week range 0.14
- YTD
- -93.36%
- 1 year
- -96.32%
Ownership
Held by insiders 55.42%
Held by institutions 5.08%
Float held by institutions 11.39%
Institutions 21
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Arch Venture Management, Llc | 0.96% | 1,444,296 | 72.94K | Sep 29, 2024 |
| Avantax Planning Partners, Inc. | 0.91% | 1,361,130 | 68.74K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.10% | 157,445 | 7.95K | Sep 29, 2024 |
| Selkirk Management Llc | 0.08% | 121,040 | 6.11K | Sep 29, 2024 |
| HRT Financial LP | 0.05% | 79,562 | 4.02K | Sep 29, 2024 |
| Fifth Lane Capital, LP | 0.05% | 76,593 | 3.87K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.10% | 144,145 | 7.28K | Oct 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ATWOOD BRIAN G | Director | Conversion of Exercise of derivative security | Sep 24, 2024 | 0 |
| EHRLICH CHRISTOPHER B | Chief Executive Officer | Conversion of Exercise of derivative security | Sep 24, 2024 | 5,795,410 |
| LAPORTE KATHLEEN D | Director | Conversion of Exercise of derivative security | Sep 24, 2024 | 0 |
| SLOAN STUART M | Beneficial Owner of more than 10% of a Class of Security | Sale | Sep 24, 2024 | 0 |
| YK BIOVENTURES OPPORTUNITIES GP I, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Sale | Dec 12, 2024 | 0 |